D. Cambridge
Impact in
-
- Neuropeptides and Animal Physiology
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Physiology top 10%
- Nitric Oxide and Endothelin Effects
- Pain Mechanisms and Treatments
Papers in
-
- Receptor Mechanisms and Signaling 10
-
- Renin-Angiotensin System Studies 8
- Co-authors
- R. Massingham (4 shared papers)Michael Davey (3 shared papers)Graeme R. Martin (3 shared papers)Salvador Moncada (1 shared paper)Daryl D. Rees (1 shared paper)P. Leff (1 shared paper)G. Allan (6 shared papers)Heather Giles (6 shared papers)
- Journals
- British Journal of Pharmacology (8 papers)Archiv der Pharmazie (3 papers)European Journal of Pharmacology (3 papers)Journal of Medicinal Chemistry (2 papers)Cardiovascular Research (2 papers)
- Partner nations
- United KingdomUnited States
In The Last Decade
D. Cambridge
29 papers receiving 840 citations
Peers
Comparison fields: 5 of 100
- Cellular and Molecular Neuroscience 275
- Physiology 260
- Biochemistry 68
- Behavioral Neuroscience 26
- Cardiology and Cardiovascular Medicine 148
Countries citing papers authored by D. Cambridge
This map shows the geographic impact of D. Cambridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Cambridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Cambridge more than expected).
Fields of papers citing papers by D. Cambridge
This network shows the impact of papers produced by D. Cambridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Cambridge. The network helps show where D. Cambridge may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Cambridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 256 | |
| 2 | Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. | 1977 | 117 |
| 3 | 1977 | 102 | |
| 4 | 1998 | 77 | |
| 5 | 1987 | 65 | |
| 6 | 2001 | 40 | |
| 7 | 1986 | 39 | |
| 8 | 1990 | 35 | |
| 9 | 1995 | 32 | |
| 10 | 1986 | 27 | |
| 11 | 1995 | 19 | |
| 12 | 1990 | 18 | |
| 13 | 1987 | 15 | |
| 14 | 1981 | 15 | |
| 15 | 1998 | 11 | |
| 16 | 1988 | 10 | |
| 17 | 1992 | 7 | |
| 18 | 1993 | 6 | |
| 19 | 1991 | 6 | |
| 20 | 1988 | 5 |
About D. Cambridge
D. Cambridge is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Organic Chemistry and Physiology, having authored 31 papers that have together received 934 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Renin-Angiotensin System Studies (8 papers), Migraine and Headache Studies (4 papers), Neuropeptides and Animal Physiology (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Hemodynamic Monitoring and Therapy (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (275 citations), Physiology (260 citations), Biochemistry (68 citations), Behavioral Neuroscience (26 citations) and Cardiology and Cardiovascular Medicine (148 citations). D. Cambridge has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include R. Massingham, Michael Davey, Graeme R. Martin, Salvador Moncada, Daryl D. Rees, P. Leff, G. Allan, Heather Giles, Robert C. Glen and Alan P. Hill. Their work appears in journals such as British Journal of Pharmacology, Archiv der Pharmazie, European Journal of Pharmacology, Journal of Medicinal Chemistry and Cardiovascular Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.